Pharmacology and rationale for imatinib in the treatment of scleroderma

Overview of attention for article published in Journal of experimental pharmacology, April 2013

Altmetric Badge

About this Attention Score

Among the highest-scoring outputs from this source (#42 of 150)
Good Attention Score compared to outputs of the same age (66th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 26 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

TOPICAL TREATMENT OF LOCALIZED SCLERODERMA

Application EP-3019170-A4

European Patent Office